Misericordia University

Misericordia Digital Commons
Doctor of Nursing Practice (DNP) Program

College of Health Sciences and Education

8-1-2015

The Effectiveness of Implementing Standard of
Care Best Practices Including Use of Daily
Incentive Spirometry to Improve Dyspnea and
Quality of Life in Adults with Chronic Obstructive
Pulmonary Disease (COPD)
Christine Gallagher
Misericordia University

Follow this and additional works at: https://digitalcommons.misericordia.edu/dnp_etd
Part of the Nursing Commons, and the Therapeutics Commons
Recommended Citation
Gallagher, Christine, "The Effectiveness of Implementing Standard of Care Best Practices Including Use of Daily Incentive Spirometry
to Improve Dyspnea and Quality of Life in Adults with Chronic Obstructive Pulmonary Disease (COPD)" (2015). Doctor of Nursing
Practice (DNP) Program. 1.
https://digitalcommons.misericordia.edu/dnp_etd/1

This Thesis is brought to you for free and open access by the College of Health Sciences and Education at Misericordia Digital Commons. It has been
accepted for inclusion in Doctor of Nursing Practice (DNP) Program by an authorized administrator of Misericordia Digital Commons. For more
information, please contact jsluzele@misericordia.edu, mcech@misericordia.edu.

The Effectiveness of Implementing Standard of Care Best Practices Including Use of
Daily Incentive Spirometry to Improve Dyspnea and Quality of Life in Adults with
Chronic Obstructive Pulmonary Disease (COPD)
by
Christine Gallagher MSN, CRNP, NP-C
Submitted In Partial Fulfillment of the Requirements
For the Degree of
Doctor of Nursing Practice
Misericordia University
August 2015

__________________________________
Signature of Faculty Reader

__________________________________
Signature of Director of DNP Programs

___________
Date

8/24/2015
___________
Date

Copyright by
Christine Gallagher MSN, CRNP, NP-C
2015

Acknowledgements
I would like to thank my family and friends, especially my husband and daughter,
for all of the support and encouragement they have provided me through this process. I
would like to thank the Lord for all he has given me and for giving me the strength to
follow my dreams. I would also like to thank Dr. Brenda Hage and Dr. Cheryl Fuller, for
all of the encouragement and support and help they have provided me during the
program. I especially want to thank my classmates throughout this program, we have all
stuck by each other, supported each other, and held each other up through all of the
demands of the program and achieved our dreams.

i

List of Figures
Figure 1……………………………………………………………………….87
Figure 2……………………………………………………………………….87

ii

Abstract
Chronic obstructive pulmonary disease (COPD) is a common preventable and
treatable disease characterized by symptoms of dyspnea, cough, and wheezing. Many
patients with COPD are on daily medications for their symptoms yet these symptoms
continue to persist, impairing their quality of life. Patients with COPD experience
respiratory muscle weakness that contributes to dyspnea and an inability to participate in
daily activities. GOLD (2014) guidelines state that the goal of therapy in these patients is
to reduce symptoms, increase participation in activities, and restore the highest level of
independent functioning. The guidelines recommend the use of inspiratory muscle
training (IMT) in the plan of care for these patients in order to reduce symptoms and
studies have shown that an incentive spirometer can be used to perform IMT effectively.
The incentive spirometer is a simple, cost-effective device that encourages deep
breathing, which promotes lung expansion. The purpose of the EBP project was to
improve quality of life and dyspnea in adult patients, ages 45-70, with COPD through the
daily use of incentive spirometry. The project was based on the GOLD (2014)
guidelines. The St. George’s Respiratory Questionnaire and Visual Analogue Scale for
breathlessness were administered before and after the protocol and scores were
compared. The project showed a decrease in dyspnea and improvement in quality of life
after an eight week intervention period. The results of this project demonstrated that
including IMT in the plan of care for patients with COPD can reduce dyspnea and
improve quality of life, leading to quality, cost-effective, accessible care and optimal
outcomes in these patients.
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Chapter 1
Introduction and Overview of the Problem of Interest
Chronic Obstructive Pulmonary Disease (COPD) is a significant chronic disease
affecting about 1.5 million individuals in the United States (Yang, Taylor & Blackstock,
2010). Approximately 25% of individuals with COPD are admitted to an acute care
hospital each year with an exacerbation of the disease (Yang, Taylor & Blackstock,
2010). The estimated direct costs of the disease are $29.5 billion with exacerbations
accounting for the greatest proportion of the burden (GOLD, 2014). COPD is the fourth
most common cause of death in the United States and is expected to be the third most
common cause of death by the year 2020 (Heydari, Farzad & Hosseini, 2013). Mortality
from the disease has more than doubled over the past twenty years (Celli, MacNee,
Augusti, Anzueto, Berg, Buist,…ZuWallack, 2004).
COPD has been known to substantially impair quality of life and increase the risk
of premature death (Petrovic, Reiter, Zipko, Pohl & Wanke, 2012). Patients with COPD
experience respiratory muscle weakness which contributes to the sensation of dyspnea
(Heydari, Farzad & Hosseini, 2013). Dyspnea is a cardinal symptom of the COPD and a
major cause of disability and anxiety associated with the disease (GOLD, 2014). Daily
activity is frequently limited and health related quality of life is reduced due to dyspnea
(Shinde, Kiran, Khatri & Hande, 2012). The Disability Adjusted Life Year (DALY)
estimates the fraction of disability attributable to major diseases and COPD is projected
to be the seventh leading cause of DALY’s lost worldwide by 2020 (GOLD, 2014).

2

Early literature on the use of inspiratory muscle training in patients with COPD
presented a mixed opinion but current GOLD (2014) guidelines recommend the use of
inspiratory muscle training as part of a pulmonary rehabilitation program for these
patients to improve dyspnea and quality of life (Geddes, Reid, Crowe, O’Brien & Brooks,
2005).
This evidence-based practice change project focuses on the use of incentive
spirometry for inspiratory muscle training to decrease dyspnea and improve quality of life
in individuals with COPD. The project and it’s implication for advanced nursing practice
will be discussed in this paper.
Background
COPD is a common preventable and treatable disease that is characterized by
persistent airflow limitation, air trapping, and hyperinflation of the lungs, which puts the
inspiratory muscles at a mechanical disadvantage (GOLD, 2014; Shinde, Kiran, Khatri &
Hande, 2012). The airflow limitation is usually progressive and associated with a chronic
inflammatory response in the airways and lungs due to noxious particles and gases
(GOLD, 2014). The disease can be characterized by chronic cough, dyspnea, wheezing,
and increased mucous secretions and is associated with a functional weakness of the
inspiratory muscles (Satani, Khuman & Nambi, 2013). COPD can substantially impair
the individual’s quality of life and increase the risk of premature death (Petrovic, Reiter,
Zipko, Pohl & Wanke, 2012).
COPD produces obstruction to the flow of air which affects the mechanical
function and gas exchange of the lungs (Satani, Khuman & Nambi, 2013). These patients
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also experience alterations in the mechanics of the chest wall that reduces the
effectiveness of the diaphragm and increases the work of breathing (Shinde, Kiran, Khatri
& Hande, 2012). The respiratory muscles must work harder in order to overcome this
resistance which in turn leads to respiratory muscle weakness (Satani, Khuman & Nambi,
2013). Respiratory muscle weakness contributes to hypercapnia, dyspnea, oxygen
desaturation, and reduced walking distance (Gosselink, DeVos, van den Huevel, Segers,
Decramer & Kwakkel, 2011). Dyspnea is an important and most debilitating symptom in
these patients and frequently limits daily activity and reduces a patient’s health related
quality of life (Shinde, Kiran, Khatri & Hande, 2012). Drug therapy is the mainstay in
treatment for patients with COPD, followed by physical rehabilitation, which has been
the only method proven to reduce dyspnea (Satani, Khuman & Nambi, 2013).
Respiratory rehabilitation has been recognized as an important part of the management in
patients with COPD (Shinde, Kiran, Khatri & Hande, 2012). It is a multidisciplinary
program of care that can be individually tailored and designed for each patient to
optimize physical and social performance, and patient autonomy (Celli et al., 2004).
Controlled breathing is included in respiratory rehabilitation programs and has been
shown to relieve dyspnea by increasing strength and endurance of the respiratory muscles
(Gosselink, 2003). The aim of respiratory rehabilitation is to improve ventilation and gas
exchange and it has been shown to improve respiratory function, decrease dyspnea, and
improve exercise tolerance and quality of life in patients with COPD (Shinde, Kiran,
Khatri & Hande, 2012). Respiratory rehabilitation is recommended by the GOLD
guidelines (2014) for a non-pharmacologic therapy in patients with COPD. Inspiratory
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muscle training (IMT) is an important and common component of respiratory
rehabilitation that improves the strength and endurance of the respiratory muscles (Satani,
Khuman, Devi & Nambi, 2013). Studies have shown that placing a load on respiratory
muscles during inspiration can increase the strength of respiratory muscles, causing a
meaningful reduction in dyspnea (Heydari, Farzad & Hosseini, 2013). GOLD guidelines
(2014) list the many benefits of respiratory rehabilitation which include improved quality
of life, reduced anxiety and depression associated with COPD, improved survival, and
reduced sensation of breathlessness. One of the devices used for inspiratory muscle
training is the incentive spirometer, which offers resistance while performing inspiration
(Satani, Khuman, Devi & Nambi, 2013). The incentive spirometer is a simple, costeffective device which provides visual feedback to the patient while performing
inspiration so that the patient can achieve goals (Satani, Khuman, Devi & Nambi, 2013).
Incentive spirometry encourages deep breathing and sustained inspiration, a more
controlled flow of breathing, and greater enthusiasm to practice IMT in patients (Satani,
Khuman, Devi & Nambi, 2013). The device is designed to mimic natural sighing or
yawning by encouraging the patient to take slow, long, and deep breaths (Restepro,
Wettstein, Wittnebel & Tracy, 2011). This mechanism decreases pressure in the lungs,
promoting increased lung expansion and when repeated on a regular basis, has the ability
to prevent or reverse atelectasis (Restepro, Wettstein, Wittnebel & Tracy, 2011). Studies
have shown that the daily use of incentive spirometry resulted in improved quality of life
and decreased dyspnea in patients (Basoglu, Atasever & Backagolu, 2005; Satani,
Khuman, Devi & Nambi, 2013). Guidelines for the use of incentive spirometry
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recommend the use of the device in the presence of pulmonary atelectasis or in conditions
that may predispose individuals to atelectasis when used in the presence of restrictive
lung defects (Restepro, Wettstein, Wittnebel & Tracy, 2011).
Significance
COPD is a leading cause of morbidity and mortality worldwide and results in an
economic and social burden that is substantial and continues to increase (GOLD, 2014).
The prevalence and burden of the disease are expected to increase in the coming years
due to the continued exposure of COPD risk factors and the aging of the population
(GOLD, 2014). COPD is a major health problem in the United States with the mortality
rate rising yearly (Halpern, Stanford & Borker, 2003). The disease is associated with a
significant economic burden as well. In the United States, the economic burden of COPD
is estimated at $29.5 billion for direct costs and exacerbations of the disease account for
the greatest proportion of the total burden to the healthcare system in the United States
(GOLD, 2014). In addition to direct costs, COPD has been shown to have a major
impact on non-medical costs as well, due to lost productivity, at a cost of $14.1 billion
(Halpern, Stanford & Borker, 2003). When taking into consideration the burden that this
disease places on patients with the disease and the healthcare system, one can see the
significance of the problem in primary care and the importance for healthcare providers
to work with these patients to improve respiratory muscle function. COPD remains a
chronic public health problem and its systemic effects have been recognized in other
body systems which can further impair the lives of these patients, resulting in lost work
days (Heydari, Farzad & Hosseini, 2013). One-third of patients reported that they were
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prevented from going to work because of their COPD symptoms and approximately
seven percent of caregivers of these individuals have reported work loss (Halpern,
Stanford & Borker, 2003). Airflow limitation and hyperinflation affect cardiac function
and gas exchange, inflammatory mediators in the circulation may contribute to skeletal
wasting and cachexia, and the disease may irritate or worsen comorbidities such as
ischemic heart disease, heart failure, osteoporosis, normocytic anemia, diabetes,
metabolic syndrome, and depression (GOLD, 2014). Individuals with the disease also
experience a social burden as well and are limited in their participation in daily activities
and many may experience social isolation due to their limitations (GOLD, 2014).
Advanced practice nurses (APN’s) play an important role in identifying potential
candidates for respiratory muscle training and in facilitating and reinforcing the material
learned in the program (Heydari, Farzad & Hosseini, 2013). Advanced practice nurses
have the ability to define, identify and analyze outcomes to improve the health status of
individuals and populations (Curley & Vitale, 2012). Advanced practice nurses can
facilitate care processes that can result in the achievement of outcomes for individuals or
groups of patients through education, counseling, direct clinical practice, and
coordination of care (Hamric, Spross & Hanson, 2009). When considering the morbidity
and mortality of COPD, the APN can use the information to find available resources and
develop innovative interventions for patients in order to improve their quality of life and
decrease the sensation of dyspnea they experience (Curley & Vitale, 2012).
System and Population Impact
COPD affects individuals from all socioeconomic levels and not all patients have
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access to formal rehabilitation programs which makes it important for the advanced
practice nurse to facilitate these services for patients in need (Heydari, Farzad &
Hosseini, 2013). Using a simple tool such as incentive spirometry for respiratory
rehabilitation can greatly improve the ability of the advanced practice nurse to provide
these individuals with more feasible and accessible care (Heydari, Farzad & Hosseini,
2013). The device is inexpensive and easy to use, which makes its use in areas of health
disparities, such as in the underinsured and uninsured, essential (Restepro, Wettstein,
Wittnebel & Tracy, 2011).
Question Guiding Inquiry
Considering the importance of reduction of dyspnea and improvement in quality
of life for patients with COPD, the advanced practice nurse may ask the following
question: “In adults ages 45-70 with COPD, does the daily use of incentive spirometry
result in decreased dyspnea and improved quality of life over an eight week period?”
Purpose
The population of interest for this evidence-based project are male and female
adults, ages 45-70, with a documented diagnosis of COPD, are compliant with care, and
are English speaking. These patients may currently be using medications for COPD,
which may include bronchodilators, long and short acting beta-agonists, systemic
corticosteroids, and inhaled corticosteroids (ICS). Patients excluded from the proposed
project would be those with co-morbid conditions, non-compliant patients, and those with
a history of pneumothorax.
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The intervention the PICO-T is proposing is the daily use of incentive spirometry
as a form of inspiratory muscle training over an eight week period combined with
telephone follow up every two weeks, to reduce dyspnea and improve quality of life in
patients with COPD. The outcome of interest is the reduction of dyspnea and improved
quality of life, self-reported by patients, using St. George’s Respiratory Questionnaire
(2005) and a Visual Analogue Scale (1999) for dyspnea. These measurements would be
evaluated at the start and end of the project. Patients will also be provided with a daily
symptom diary to record their symptoms and to document the use of the intervention in
order to reduce the potential for participant recall bias. The follow up telephone calls
every two weeks would be used as a way to assess compliance and to respond to any
concerns or questions at that time.
Aims/Objectives
The objective of the project is to implement an evidence based practice protocol
using incentive spirometry as a means of inspiratory muscle training when treating
patients who present to the urgent care setting with complaints of dyspnea and impaired
quality of life. The objective is to determine if the use of daily incentive spirometry
would result in patients reporting a decrease in dyspnea and improvement in their quality
of life. Intended users of the protocol would include advanced practice nurses, physician
assistants, and physicians. Impaired functional status and dyspnea are critical features of
COPD and the goals of using respiratory rehabilitation in these patients is to reduce
symptoms, improve activity, and restore the highest level of independent function
possible (Lan, Chu, Yang, Lee, Wu & Wu, 2013). Exercise capacity is important because
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it directly correlates with mortality in patients with COPD, so if this can be improved,
mortality from the disease can be reduced and thus, hopefully improve the health of this
population (Lan, Chu, Yang, Lee, Wu & Wu, 2013). When evaluating the many benefits
of respiratory muscle training in patients with COPD and upon review of evidence
presented in clinical guidelines, it is essential that this is included in the plan of care for
these patients in order to improve their quality of life and decrease associated symptoms
and mortality from the disease.
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Chapter 2
Review of the Evidence/Literature
Patients with COPD experience respiratory muscle weakness that contributes to
dyspnea, which is the most debilitating symptom in these patients and can reduce health
related quality of life (Gosselink, DeVos, van den Huevel, Segers, Dekramer& Kwakkel,
2011; Shinde, Kiran, Khatri & Hande, 2012). Guidelines recommend the use of respiratory
rehabilitation as a therapy in patients with COPD (GOLD, 2014). COPD is the leading
cause of morbidity and mortality in the world and has resulted in an economic and social
burden that is substantial and continues to increase daily (GOLD, 2014). Considering this,
it is important for clinicians to seek out the current best evidence and apply it in their daily
practice in order to improve outcomes in this population. One of the most important
reasons for implementing evidence based practice (EBP) is that it leads to the best quality
of care and the best patient outcomes (Melnyk & Fineout-Overholt, 2011).
Evidence evolves continually, so it is important that clinicians include the latest
evidence in their practice (Melnyk & Fineout-Overholt, 2011). Without current best
evidence, practice can become rapidly outdated, which can be detrimental to patients
(Melnyk & Fineout-Overholt, 2011). The purpose of a literature review is to provide
information about existing current evidence related to a question of inquiry (Melnyk &
Fineout-Overholt, 2011). The literature review supports the value or the need to study a
phenomena of interest and is used to present data that support the need for the project and
how the project is needed to address the findings (Moran, Burson & Conrad, 2014). This
literature review was performed based on a systematic, thorough, and rigorous approach in
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order to ensure the quality of evidence obtained. The literature obtained describes concepts
related to the use of inspiratory muscle training in COPD patients in relation to improving
inspiratory muscle strength and improving dyspnea and quality of life as well as to identify
areas where further inquiry is needed.
Methodology
The purpose of this section is to briefly describe the strategy that was used to select
and review the articles that were used in the literature review. In order to find evidence to
support the evidence based practice project, a systematic database literature search that
encompassed the years 2005 to 2014 was performed using the keywords or terms “chronic
obstructive pulmonary disease”, “COPD guidelines”, “incentive spirometry guidelines”,
“incentive spirometry”, “inspiratory muscle training”, “quality of life”, and “dyspnea”.
Delimiters were used during the literature search such as “incentive spirometry and
COPD”, “inspiratory muscle training and COPD”, and “inspiratory muscle training and
incentive spirometry”. Databases searched were CINAHL, Academic Search Premier,
Medline, and PubMed. The databases were chosen due to the fact that they are well known
and credible sources that contain current information related to the area of interest in the
evidence based practice project. Inclusion criteria for the search were adults, male and
female patients, ages 45-70, diagnosed with COPD. Those studies not published in English
or not using inspiratory muscle training were excluded. Literature that appeared as letters
to the editor was also excluded. The above mentioned search terms resulted in twenty four
results in Academic Search Premier, 164 results in CINAHL, 164 results in Medline, and
287 results in PubMed. Abstracts of the results were then read to determine if the area of
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interest, inclusion and exclusion criteria, intervention, and outcomes of interest were
similar to those in the proposed evidence based practice project. After a review of the
literature, nine articles were identified that met the criteria to support the proposed evidence
based practice project. Those that were chosen are Level I and II evidence which consist
of randomized controlled trials, systematic reviews, meta-analyses, and clinical guidelines,
because these are the strongest levels of evidence and are the least biased way to
demonstrate with confidence that the interventions will consistently bring about an
outcome (Melnyk & Fineout-Overholt, 2011).
Findings (Critical Appraisal of the Literature)
Randomized Controlled Trials
Basoglu, Atasever & Backagoglu (2005) conducted a randomized controlled trial
to evaluate the effects of incentive spirometry on pulmonary function tests, arterial blood
gases, dyspnea, and health related quality of life in patients with COPD. The incentive
spirometer was used as an inspiratory muscle trainer in this study.
The participants in the study were thirty two (n=32) patients hospitalized with an
exacerbation of COPD and were either given medications for COPD and asked to
undertake incentive spirometry (n=16) or given only medical treatment (n=16). The
intervention and comparison were the addition of daily use of incentive spirometry in
addition to typical COPD medications and the outcome was to determine if there was an
improvement in pulmonary function tests, arterial blood gases, dyspnea, and quality of life.
Patients received follow up telephone calls every two weeks during the intervention period
and had a follow up visit at two months from the start of the intervention period.
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After patients were recruited for the study, they were randomized to either the
medical treatment group (n=16) or the group with incentive spirometry plus medical
treatment (n=16), through a computer random generator.

Due to the computerized

randomization, the study and control groups were not matched, however when
demographics for both groups were reviewed, they appeared similar and a chart was
provided to substantiate this. There was no mention of concealment or blinding in the
study. Prior to the beginning of the study, a power calculation was done. The authors
provided the number of patients who withdrew from the study and the reasons for
withdrawal.
Participants in the study had arterial blood gases and pulmonary function tests and
completed visual analogue scales (VAS) for breathlessness and the St. George’s
Respiratory Questionnaire (SGRQ) at the beginning and end of the study and the authors
provided a chart to compare the pre- and post-treatment values for these. P values were
reported as p<0.0001 for both. Based on the above, the study should be considered valid
with some caution.
The study states that the researchers used the student’s t-test to analyze parametric
measures. The analysis of categorical variables was done using the X2 test, Fisher’s exact
test, or the Mann-Whitney U-test. Results are expressed with a 95% confidence interval
(CI) and p values are expressed when there was statistical significance. Between the two
groups, the activity impact and total SGRQ scores were improved by the use of incentive
spirometry (95% CI; p<0.0001). VAS scores in the incentive spirometry treatment group
decreased from 8.3 +/- 1.2 to 7.7 +/- 1.4. The PaCO2 decreased in the incentive spirometry
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group (95% CI; p= 0.02) and the PaO2 increased as well (95% CI; p=0.01). These findings
show that the use of incentive spirometry along with medical treatment improved arterial
blood gases, dyspnea, and health related quality of life. The use of incentive spirometry
was shown to increase inspiratory muscle performance in this study. The authors do
suggest that the study may be performed in the future using a larger number of subjects
and also in stable COPD patients. There were several limitations noted in the study, one
of these being a small amount of participants. Results would vary in relation to a larger
number of participants and may provide more support for the intervention.

Most

participants in the study were males. This is not representative of most COPD patients
because the disease affects both males and females. Based on the findings, the study should
be considered reliable with some caution.
Petrovic, Reiter, Zipko, Pohl & Wanke (2012) conducted a randomized controlled
trial to analyze the effects of inspiratory muscle training (IMT) on exercise capacity and
dyspnea in patients with COPD. The participants in the study were twenty (n=20) patients
with COPD who were recruited from an outpatient clinic and either underwent IMT or
didn’t. The outcomes measured were inspiratory muscle capacity and dyspnea. The timing
of follow up was eight weeks.
After participants were recruited into the study, they were randomized to either the
IMT group (n=10) or the control group (n=10). Although the authors state that the
participants were randomized to the groups, no mention is made as to how the
randomization occurred or if there was blinding. There is no mention made of a power
calculation or ITT analysis being performed prior to the start of the study. There was no
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mention of patient withdrawal from the study.

A chart was provided to show the

characteristics of both groups at baseline and both groups appear similar. The intervention
and control management were described in the article. Based on the above, the study
should be considered valid with some caution.
The study states that the authors used the Shapiro-Wilk test for preliminary testing
to evaluate if the grouped data were normally distributed (p<0.05). Results are expressed
with a 95% CI and p values are expressed when there was statistical significance. The IMT
training group showed a significant increase in inspiratory muscle performance after eight
weeks of daily IMT when compared to the control group (95% CI; p<0.001). The level of
dyspnea showed a significant decrease after eight weeks of daily IMT (95% CI; p<0.01).
Inspiratory capacity also increased in the treatment group when compared to the control
group (95% CI; p<0.001). Charts were provided for comparison of spirometric data values
at the start and end of the intervention period. ANOVA was done for analysis of between
group effects analysis. No limitations of the study were mentioned by the authors,
however, the small number of participants can be considered a limitation. Another
limitation of the study was that participants only performed inspiratory muscle training
once per day. Based on the above, the study should be considered reliable with some
caution.
Heydari, Farzad & Hosseini (2013) conducted a randomized controlled trial to
examine the effect of incentive spirometry on pulmonary rehabilitation in COPD patients
compared to using inspiratory resistive muscle training technique. The participants in the
study were 30 (n=30) patients with COPD that were randomized to either an IMT group
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(n=15) or an incentive spirometry group (n=15). The outcomes measured were respiratory
function test values. The timing of the follow up was four weeks.
After patients were recruited for the study, they were randomized to either the IMT
group (n=15) or the incentive spirometry group (n=15), however no mention is made as to
how the randomization occurred. Prior to the beginning of the study, a power calculation
was done in order to reduce the risk of a Type II error. There was no mention of any patient
withdrawal and all participants completed the study. There is no mention of blinding in
the study. A chart was provided to show baseline characteristics of both groups and both
groups appear similar except that there were more male subjects than female subjects in
both groups. P values are provided in this chart. The intervention and control management
were described in the article. Based on the above, the study should be considered valid
with some caution.
The study states that ANOVA was performed for within group analysis of variance.
Results are expressed with a CI of 95% and p values are expressed where there was
statistical significance. The findings showed significant differences between the mean
values of each respiratory function test for both techniques (95% CI; p<0.001). For the
value of peak expiratory flow rate (PEFR), incentive spirometry was shown to be more
effective than IMT (95% CI; p=0.021). A chart was provided to compare respiratory
function tests before, during, and after intervention, with p values listed. It was determined
by the authors that breathing exercises improved dyspnea in the incentive spirometry group
as a result of improved inspiratory muscle performance. The authors of the study listed
that they limited time to pursue long term effects of the interventions and that the findings
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may not be generalizable to patients with severe COPD or an unstable cardiovascular
status. Based on the above, the study should be considered reliable with some caution.
The findings of the appraised RCT’s support the proposed evidence based practice
project because the goal of the project is to use incentive spirometry as an inspiratory
muscle trainer to improve quality of life and decrease dyspnea in COPD patients. Results
from these studies show that inspiratory muscle training can be an important aspect of
treatment in this population of patients in order to improve patient outcomes.
Systematic Reviews/Meta-Analyses
Geddes, Reid, Crowe, O’Brien & Brooks (2005) conducted an analysis of nineteen
randomly controlled trials (RCT’s) to determine the effect of IMT on inspiratory muscle
strength and endurance, exercise capacity, dyspnea, and quality of life for adults with
COPD. The criteria for considering studies to include in the review was explained and
only studies that used randomized design to allocate patients to groups, English
publications, and adult participants were used. The authors performed a structured search
of Medline and CINAHL from the inception dates of the databases up to 2003 for limits.
The search strategy was included in the text of the review. Reference lists from pertinent
articles and books were searched, authors were contacted personally, and targeted journals
were hand searched to identify any relevant articles for inclusion. Studies were chosen if
they compared IMT to another comparison group. A flow chart was provided that showed
the amount of RCT’s that were included and excluded and the reasons as to why. Data
from the articles was extracted independently by two reviewers onto data abstraction forms.
Methodological quality of the studies was assessed by two reviewers using criteria by Jadad
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et al. for randomization, double-blinding, withdrawals/dropouts, and group similarities at
baseline. No mention was made as to the settings for the included RCT’s. Outcomes of
interest in the review were inspiratory muscle strength, dyspnea, and exercise capacity. A
table of studies was provided that compared the various modes of IMT that were used.
Sensitivity analyses were performed in the presence of significant heterogeneity to
determine the robustness of the findings. Funnel plots were presented in the review to
decrease the possibility of publication bias. Based on the above, the systematic review
should be considered valid.
Data was analyzed using computer software and outcomes were analyzed as
continuous outcomes using the random effects model to calculate the mean difference and
95% CI. Main findings of the review showed inspiratory muscle strength improved by
12.3cm H2O (95% CI; p<0.00001) in groups using targeted IMT and inspiratory muscle
endurance increased by 1.0kPa (95% CI; p=0.005) in these groups as well. Dyspnea was
also found to be improved in these groups (95% CI; p<0.00001). A large clinically
significant change was found for an increase in quality of life for those in IMT groups.
Main findings of the review were that targeted IMT significantly improves
inspiratory muscle strength, inspiratory muscle endurance, quality of life, and decreases
dyspnea in patients with stable COPD. All results were tested for heterogeneity and the
authors acknowledged that there was significant heterogeneity (p<0.00001) between the
studies in regards to the different forms of IMT. Based on the above, the systematic review
should be considered reliable.
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Gosselink, De Vos, van den Huevel, Segers, Decramer & Kwakkel (2011)
conducted a meta-analysis of thirty two RCT’s to investigate the effect of IMT as a single
therapy or added to general exercise training, and identify the most appropriate training
modality in terms of strength or endurance training for IMT. The criteria for considering
studies to include in the review was explained and only studies that used randomized design
to allocate patients to groups were used. The authors performed a standardized search of
databases using the publication dates up to May 2009 for limits. The search strategy was
included in an online supplement. No language restrictions were used in the search. The
search was performed by two independent reviewers and if data were not in a form
suitable for pooling, authors were contacted for additional information. Studies were
selected if they were randomized to groups, included patients with COPD, used IMT or
respiratory muscle endurance training, or if outcomes were described in terms of
inspiratory muscle strength, dyspnea, or health related quality of life. No flow chart was
provided to show the inclusion and exclusion of the RCT’s but the process was explained
in the analysis. The I2 statistic was calculated to determine heterogeneity and funnel plots
were presented in the review to decrease the possibility of publication bias. Heterogeneity
was defined if the I2 was beyond 50%. Based on the above, the meta-analysis should be
considered valid.
Data was analyzed using summary effect size (SES). The meta-analysis for
inspiratory muscle strength demonstrated a significant increase of 13 mm H2O (SES 0.68;
95% CI 0.54-0.82; p<0.001) in the treatment group compared to the control group. A
significant effect was found for dyspnea scores (SES -0.45; 95% CI -0.66- -0.24;
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p<0.00001) in the IMT training group. A significant improvement in quality of life was
also seen for the IMT training group (SES 0.34; 95% CI 0.09-0.60; p<0.01). Main findings
of the review were that IMT was superior to endurance training for improving inspiratory
muscle strength, dyspnea, and quality of life. All results were tested for heterogeneity and
the authors acknowledged that there was significant heterogeneity between the studies in
regards to the superiority of IMT for COPD patients. Based on the above, the meta-analysis
should be considered reliable.
The findings of the systematic review and meta-analysis support the proposed
evidence based practice project because the goal of the project is to use incentive
spirometry as an inspiratory muscle trainer to improve quality of life and decrease dyspnea
in COPD patients. Results from these studies show that inspiratory muscle training can be
an important aspect of treatment in this population of patients in order to improve patient
outcomes. The evidence has shown that IMT is an effective treatment modality in COPD
patients to improve inspiratory muscle strength, dyspnea, and quality of life.
Guidelines
The Global Initiative for chronic Obstructive Lung Disease (GOLD) guideline
(2014) were reviewed using the AGREE instrument. GOLD (2014) clearly stated that the
objective of the guideline is to provide recommendations for management of COPD based
on the best scientific information available. Guideline developers are clearly listed and are
known to have expertise in COPD research and patient care and represent a variety of
disciplines. The areas the guideline covers are specifically described throughout and
targeted users are defined as “those working in clinical settings anywhere in the world
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providing COPD treatment” (p. xiv) and for healthcare professionals to use as a tool to
implement effective management programs based on available health care systems. The
guideline was first piloted in 2001 with the first GOLD report.
Systematic methods were identified to search for evidence to develop future
updated versions. Members of the committee evaluate abstracts and indicate if the
scientific data impacts on the recommendations of the GOLD report. The methods for
formulating recommendations were clearly defined. Criteria for selecting the evidence is
clearly defined in the guideline. Health benefits, risks, and side effects of the various
treatment modalities were considered with discussion of treatments. Recommendations
are linked to supporting levels of evidence. Review of the guideline occurs internally and
externally. Updates are made as new data becomes available and the GOLD science
committee meets twice yearly to discuss the addition of the data to the GOLD report, either
as a reference or to change the report.
The guideline is specific and unambiguous and clearly identifies management
options. Key recommendations are identified throughout using various levels of evidence
and are presented clearly using charts and tables for easy identification. Organizational
barriers and cost effectiveness are not specifically mentioned. No conflicts of interest were
identified.
Recommendations are made for pulmonary rehabilitation in COPD patients to
reduce symptoms, improve quality of life, and increase physical participation in everyday
activities which closely relates to the proposed evidence based practice project. GOLD
recommends that IMT can be beneficial in patients with COPD. Differing types of non-
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pharmacologic therapies are included for application with COPD patients. The social and
economic burden of the disease is discussed. The GOLD guideline is appropriate for the
proposed practice change project and closely relates to the population indicated. The
recommendations can be used by healthcare providers and applied to the population of
COPD patients to improve their quality of life, decrease dyspnea, and to ensure that best
practices are used to improve outcomes in this population.
The AARC Clinical Practice Guideline on Incentive Spirometry (2011) was
reviewed using the AGREE instrument. Restepro, Wettstein, Wittnebel & Tracy have
presented the guideline to provide users with the proper use of the tool, indications and
contraindications for use, monitoring during use, frequency of use, infection control
methods, and key recommendations. Guideline developers are noted to be individuals from
various hospitals and medical centers and all are respiratory therapists. Targeted users are
identified as those in critical care, acute care inpatient settings, extended care and skilled
nursing facilities, and those in home care. No piloting of the guideline is mentioned.
Systematic methods were identified to search for evidence and the criteria for
selecting the evidence was defined. Methods for formulating key recommendations were
clearly defined using the Grading of Recommendations Assessment, Development, and
Evaluation scoring system (GRADE) and the recommendations are linked to supporting
evidence. Health benefits and risks are considered and noted. No mention is made of the
review process for the guideline. No procedures are listed for updating. There are no tables
for dissemination of recommendations but they are clearly listed at the end of the guideline.
No sources of funding are indicated and no conflicts of interest were identified.
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The recommendations can be applied to the proposed evidence based practice
project using incentive spirometry and can ensure that it is done with proper technique and
frequency. It is recommended that a volume oriented device be used, which is the typical
device used in healthcare today. No barriers to application were identified and incentive
spirometry has been shown to be an inexpensive, convenient tool to use and has been used
routinely in postoperative patients to prevent complications. The target population can
benefit from the use of the device and it is applicable to the population and users considered
in the proposed practice project.
Integrative Review of the Literature
After a thorough review of the literature, it appears that there is evidence to
support the implementation of the proposed evidence based practice project. The clinical
usefulness of the findings in the review provide APN’s with the ability to advance care in
this population. Patients with COPD experience respiratory muscle weakness which may
contribute to dyspnea and decreased quality of life (Heydari, Farzad & Hosseini, 2013).
Improvement in care for this specific population must include the addition of pulmonary
rehabilitation in order to improve quality of life (GOLD, 2014). Multiple systematic
reviews and RCT’s suggest the use of IMT for COPD patients in order to improve
inspiratory muscle function. The literature has shown that the use of IMT has resulted in
increased respiratory muscle performance, decreased dyspnea, and improved quality of
life in patients with COPD who have used the technique daily (Basoglu et al, 2005;
Petrovic et al., 2012; Geddes et al., 2005). The early literature on the use of IMT with
individuals with COPD had not been supportive of this intervention, which prompted the
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Geddes et al. (2005) systematic review to examine the effects of IMT on inspiratory
muscle strength, dyspnea, and quality of life in these individuals. IMT was found to
produce significant improvements in inspiratory muscle strength, dyspnea, and quality of
life for this population. Guidelines recommend the use of pulmonary rehabilitation in
patients with COPD in order to reduce the frequency of exacerbations and improve the
quality of life in these patients, with IMT being a modality of this. The literature has
shown that an incentive spirometer can be used to perform effective inspiration as a form
of IMT in patients with COPD (Heydari et al., 2013).
Limitations
There were several limitations that were found during the review of the literature.
Geddes et al. (2005) and Heydari et al. (2013) noted that most of the participants in their
studies were male, which doesn’t lend the findings applicable in most situations
considering that COPD affects both male and female individuals. Several of the studies
noted small sample sizes which isn’t representative of the true population of COPD
patients since a large number of patients are affected by the disease (Petrovic et al. 2012;
Basoglu et al. 2005). Most of the studies contained an intervention period from two to
eight weeks, and this was a limitation noted by Heydari et al. (2013) because it didn’t
provide the investigators with the opportunity to pursue the long term effects of the
intervention.
Conclusion
The GOLD guidelines recommend the use of pulmonary rehabilitation in patients
with COPD in order to decrease exacerbations in this population. IMT has been shown to
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be effective in increasing inspiratory muscle function thereby decreasing dyspnea and
improving quality of life. COPD morbidity and mortality is increasing worldwide and a
large majority of the population is afflicted by the disease. The disease places a large
burden on patients and the healthcare system and it is a significant problem in primary
care (Heydari et al., 2013). Implementing evidence based care such as IMT into direct
clinical practice shows improved inspiratory muscle strength, decreased dyspnea, and
improved health care quality of life in this population of patients (Basoglu et al., 2005;
Heydari et al., 2013; Petrovic et al., 2012). APN’s are in the ideal position to implement
evidence based practices in this specific population of patients. By including IMT in the
plan of care for patients with COPD, this population will receive quality care and
improved outcomes.
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Chapter 3
Organizational Framework of Conceptual Model for EBP Change
In today’s rapidly changing healthcare environment, healthcare professionals are
typically very motivated to be evidence-based practitioners in order to ensure they
provide high quality care (Melnyk & Fineout-Overholt, 2011). Evidence-based
practitioners are encouraged to consider internal evidence, the patients’ preferences and
actions, healthcare resources, and clinical expertise when making clinical decisions
(Melnyk & Fineout-Overholt, 2011). Evidence based practice (EBP) is “the integration
of best research evidence with clinical expertise and patient values to facilitate clinical
decision making” (Melnyk & Fineout-Overholt, 2011, p. 242). Evidence based practice
is a problem solving approach to clinical care that incorporates the use of current best
practice from well-designed studies, the expertise of clinicians, and the values and
preferences of patients (Fineout-Overholt, Melnyk & Schultz, 2005). When provided in a
context of caring, EBP leads to the best clinical decision making and outcomes for
patients and their families (Fineout-Overholt, Melynk & Schultz, 2005). The Institute of
Medicine (IOM) recognizes the importance of EBP and recommends its use as one of the
five core competencies for healthcare (Fineout-Overholt, Melynk & Schultz, 2005).
Advanced practice and staff nurses as well as administrators must have a foundational
knowledge as well as strong beliefs about the importance of EBP and critical skills to
support evidence-based care (Fineout-Overholt, Melynk & Schultz, 2005).
Even though EBP is important, changing clinical practice is complex and
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challenging and because of this, conceptual models and frameworks have been developed
to guide the implementation of EBP with a systematic approach (Melnyk & FineoutOverholt, 2011). The Model for Evidence Based Practice Change by Rosswurm and
Larrabee (1999) (Appendix A) is the conceptual model used in this evidence based
practice change. This evidence-based model is derived from theoretical and research
literature related to evidence-based practice, utilization of research, and change theory
(Rosswurm & Larrabee, 1999). It was revised to integrate the principles of quality
improvement, use of teamwork tools, and evidence-based translation strategies to
promote the adoption of a new practice (Melnyk & Fineout-Overholt, 2011).
The model guides practitioners through the process of evidence-based practice
change, beginning with the assessment of the need for a change practice, and ending with
the integration of an evidence-based protocol (Rosswurm & Larrabee, 1999). The model
has six phases that include (1) assess the need for change in practice; (2) link the problem
to interventions and outcomes; (3) synthesize the best evidence; (4) design a practice
change; (5) implement and evaluate the change in practice; and (6) integrate and maintain
the change in practice (Rosswurm & Larrabee, 1999).
Conceptual Definitions
Assess the need for change in practice. Key actions in this step include identifying a
practice problem or opportunity for improvement in practice, creating a team of
stakeholders to address the problem in practice, collecting internal data about the
practice, collecting external data to compare with the internal data, and linking the
practice problem with possible interventions and desired outcomes by developing a
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clinical question (Melnyk & Fineout-Overholt, 2011). It is important to justify the focus
of the EBP project because these projects can become resource intensive (Melnyk &
Fineout-Overholt, 2011). The internal and external data collection may either
substantiate current practice or support the need for the specific change in practice
(Rosswurm & Larrabee, 1999).
Link the problem interventions and outcomes. Healthcare practitioners need to define
the problem using standardized language and classifications and link the problem with
interventions and outcomes (Rosswurm & Larrabee, 1999). Using these classification
systems facilitate communication among practitioners, provide standards for determining
if care was of quality and cost-effective, and identify the needed resources (Rosswurm &
Larrabee, 1999). Key actions in this phase include identifying the types and sources of
evidence, planning the search for evidence, and conducting the search for this evidence
which should be planned and rigorous in order to find evidence of quality (Melnyk &
Fineout-Overholt, 2011). The types of quality evidence include practice guidelines,
systematic reviews, randomized controlled trials, and expert committee reports (Melnyk
& Fineout-Overholt, 2011).
Critically analyze the evidence. In this step, the selected interventions and outcomes
are refined and the best evidence is synthesized and combined with clinical judgment
(Rosswurm & Larrabee, 1999). When critically appraising the literature, the practitioner
evaluates the strengths and weaknesses of studies and identifies gaps in the available
knowledge (Rosswurm & Larrabee, 1999). The practitioner also assesses the feasibility,
benefits, and risks of implanting the new practice (Melnyk & Fineout-Overholt, 2011).
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After the synthesis of evidence, the members of the EBP team must judge whether the
body of evidence is sufficient and strong enough to support the change in practice
(Melnyk & Fineout-Overholt, 2011).
Design practice change. After the synthesis of the best evidence, practitioners describe
the process variables or the sequence of activities in the change in practice and this
usually is in the form of a protocol, procedure, or standard (Rosswurm & Larrabee,
1999). When considering a change, the practice environment, its resources, and feedback
from stakeholders are important considerations (Rosswurm & Larrabee, 1999). The
protocol should only include activities that are evidence-based and it should be designed
to guide care only for the populations that are similar to those identified in the evidence
base (Rosswurm & Larrabee, 1999). The evidence based is used in this step to guide
practitioners in identifying the anticipated patient outcomes of the practice change
(Rosswurm & Larrabee, 1999). This is the step where needed resources should be
identified and the implementation plan designed (Melnyk & Fineout-Overholt, 2011).
Implementing and evaluating change in practice. Key actions in this step include the
implementation of the protocol; evaluating the process, outcomes, and costs; and
developing conclusions and recommendations (Melnyk & Fineout-Overholt, 2011). The
implementation of the protocol will be more successful if the practitioner closely
monitors its progress and is available to answer questions throughout and follow-up
reinforcement of the practice change by the practitioner is essential (Rosswurm &
Larrabee, 1999). At the conclusion of the protocol, the data obtained are analyzed and
disseminated in charts and graphs to facilitate the interpretation of the data and the
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practitioner can then interpret the results to decide whether there were differences in the
indicators before and after the protocol was administered (Rosswurm & Larrabee, 1999).
Members of the EBP team can then use the data with verbal feedback to decide if the new
practice should be adapted, adopted, or rejected based on the feasibility, risks, and
benefits (Melnyk & Fineout-Overholt, 2011).
Integrate and maintain change in practice. If the results of the protocol support the
change in practice, strategies to initiate the change begin (Rosswurm & Larrabee, 1999).
Key actions of this step include sharing recommendations about the new practice with
stakeholders, incorporating the new practice into the standards of care, monitoring the
process and outcome indicators, and disseminating results of the project (Melnyk &
Fineout-Overholt, 2011). Continuing education and staff inservices facilitate the change
in practitioners’ behavior and can reinforce the implementation of the new evidencebased practice change (Rosswurm & Larrabee, 1999). Plans should be made for ongoing
monitoring of the change because this data can be used to identify the need for further
refinements in the new practice or the need for a new EBP project (Melnyk & FineoutOverholt, 2011). Maintaining the change in practice is ensured by providing practitioners
with the necessary resources to implement the practice change, monitoring the process
and outcomes, and by rewarding quality performance with incentives (Rosswurm &
Larrabee, 1999).
Relationship of Model to Project
When examining this model, it can easily be applied to this proposed evidencebased practice project to facilitate the proposed change in practice for patients with
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COPD. This type of model can be applied in the primary care setting or any acute setting
in order to facilitate a change in practice (Rosswurm & Larrabee, 1999). The proposed
practice change is to use incentive spirometry for daily inspiratory muscle training in
patients with COPD in order to reduce the sensation of dyspnea and improve quality of
life in these patients.
Individuals with COPD experience inspiratory muscle dysfunction and weakness
due to the effects of increased work of breathing, hyperinflation, and hypoxemia which
results in decreased respiratory muscle strength and significantly impairs quality of life
for these patients (Geddes, Reid, Crowe, O’Brien & Brooks, 2005). It is a major health
problem in the United States with the mortality rate rising yearly (Halpern, Stanford &
Borker, 2003). In reviewing patient charts, discussions with patients presenting with
frequent episodes of dyspnea, and through discussions with other clinicians and
collaborators, the sensation of dyspnea and its impact on daily activities and health
related quality of life was recognized as a problem within this population. Knowing this,
it was determined that a change in practice was needed when caring for patients with
COPD. Stakeholders included patients, practitioners, and administrators and the
proposed practice change was discussed with all involved. Internal and external data was
collected regarding current problems in patients with the disease, cost and burdens
associated with COPD and current practices in the treatment and management of the
disease. Data sources included patient charts, quality improvement data, and discussion
with patients and caregivers. Once collected, the data was compared to determine which
intervention would be of benefit to these individuals to improve inspiratory muscle

32

strength, decrease dyspnea, and improve quality of life. After analyzing the data, it was
determined that impaired respiratory muscle strength was a problem in this population
and that improvement in this area would be of great benefit to those with the disease.
Once the problem was identified, potential interventions were examined to
determine which would be useful to this population and outcomes were determined to be
a decrease in the sensation of dyspnea and the improvement of quality of life for these
individuals. The problem of decreased respiratory muscle strength was linked with the
intervention of daily inspiratory muscle training with an incentive spirometer which was
then included in a protocol for adult patients with COPD. Outcomes identified were that
of decreased sensation of dyspnea and improved quality of life as measured by a Visual
Analogue Scale for breathlessness and the St. George’s Respiratory Questionnaire.
The literature was then reviewed, which focused on COPD, incentive spirometry,
inspiratory muscle strength, quality of life, and dyspnea. The obtained literature was then
critically analyzed and placed on a table of evidence in order to evaluate the strength of
the literature available. The research evidence was then synthesized to determine which
interventions were most effective for the desired outcomes in this population and the
evidence was then combined with clinical judgment to determine the best possible
intervention for these individuals. The evidence determined that inspiratory muscle
training significantly improved inspiratory muscle strength, decreased dyspnea, and
improved the quality of life in patients with COPD and that an incentive spirometer was a
common tool used for IMT (Basoglu, Atasever & Backagolu, 2005; Heydari, Farzad &
Hosseini, 2013; Petrovic, Reiter, Zipko, Pohl & Wanke, 2012) Once the intervention was
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determined, the feasibility, risks, and benefits of the intervention were determined in
order for the intervention to be applied successfully in this population of individuals. An
incentive spirometer is an inexpensive and simple device that can be used at the bedside
for inspiratory muscle training and also gives patients visual feedback to monitor and
encourage their progress (Basoglu, Atasever & Backagoglu, 2005).
The proposed change in practice was defined and discussed with office
practitioners, nursing staff, office managers, faculty mentor, and physician mentor.
Needed resources were identified and incentive spirometers were obtained for use by the
patients involved in the protocol. Tools that would be used to measure outcomes were
determined to be the Visual Analogue Scale for breathlessness and the St. George’s
Respiratory Questionnaire (SGRQ). Visual analogue scales for breathlessness were
developed along with a daily symptom diary and the St. George’s Respiratory
Questionnaire was obtained. Nursing staff and stakeholders were educated in the use of
the evidence-based protocol.
The evidence-based practice protocol was implemented in an outpatient care
setting and the protocol was monitored throughout the entire process. Data was collected
and findings were analyzed to determine if the protocol was effective in this population
and if the desired outcomes were met. After analysis, findings supported the change in
practice, and adoption of the protocol was recommended with minor revisions as needed.
A meeting was held with all stakeholders involved to review the protocol and
proposed revisions if needed. The evidence-based protocol was then presented to the
hospital and practice administrators and information about the protocol and its results
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were communicated to administrators and collaborating practitioners. Inservice
education was conducted with clinic staff about the protocol and its use. An ongoing
monitoring plan was devised to ensure quality outcomes for this population of patients
and to revise protocol as needed.
Use of the Rosswurm and Larrabee (1999) model can prove to be beneficial in the
development and implementation of this evidence-based practice protocol to provide
quality care to adult individuals with COPD. The model is easy to use and follows a
systematic process in order to ensure successful implementation of the practice change.
Today’s healthcare environment is supportive of evidence-based practice that will
improve the quality of patient care and enhance clinical judgment and this framework can
be useful to practitioners seeking to successfully change to evidence-based practice in a
variety of healthcare settings (Rosswurm & Larrabee, 1999).
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Chapter 4
Chronic obstructive pulmonary disease (COPD) is a common preventable and
treatable disease that is characterized by persistent airflow limitation and currently affects
about 1.5 million individuals (GOLD, 2014). The airflow limitation is usually
progressive and can substantially impair one’s quality of life and increase the risk of
premature death (Petrovic, Reiter, Zipko, Pohl & Wanke, 2012). Individuals with COPD
experience inspiratory muscle dysfunction due to the increased work of breathing and
hyperinflation, resulting in decreased inspiratory muscle strength and endurance, which
presents as dyspnea (Geddes, Reid, Crowe, O’Brien & Brooks, 2005). The airflow
obstruction affects both the mechanical and gas exchange functions of the lungs and the
respiratory muscles must work harder to overcome the resistance which leads to
weakness of the respiratory muscles (Satani, Khuman, Devi & Nambi, 2013).
Inspiratory muscle training (IMT) is an important part of pulmonary rehabilitation
which improves the strength and endurance of the respiratory muscles (Satani, Khuman,
Devi & Nambi, 2013). Incentive spirometry has been widely used as a form of
inspiratory muscle training to improve inspiratory muscle strength and to reduce dyspnea
(Satani, Khuman, Devi & Nambi, 2013). IMT has also been associated with structural
changes in the inspiratory muscle fibers (Geddes, Reid, Crowe, O’Brien & Brooks,
2005). Improving inspiratory muscle strength and endurance is a strategy that may help
to relieve the sensation of dyspnea, which leads to an increased level of activity and
improved quality of life in individuals with COPD (Geddes, Reid, Crowe, O’Brien &
Brooks, 2005). Improving the quality of life and decreasing dyspnea in these individuals
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can lead to optimal outcomes in disease management.
This chapter will provide an overview of the planning stages and design of this
evidence based practice project.
Purpose of the Project
This evidence based practice change project was designed to improve the
sensation of dyspnea and improve the quality of life in individuals with COPD. The
purpose of this project is to use incentive spirometry as IMT in conjunction with normal
medical care to improve outcomes in this population. IMT has been shown to decrease
dyspnea and improve quality of life in these individuals, which thereby leads to increased
productivity and decreased work days lost due to exacerbations of the disease. The
project will evaluate the effectiveness of implementing standard of care best practices in
the care of patients with COPD.
IRB Approval
Human Subjects Certification was completed through the National Institutes of
Health on November 5, 2014 (Appendix B). Misericordia University IRB forms and
documentation to include participant consent forms, permission letter from
institution/mentor to conduct the project, and data collection tools (St. George’s
Respiratory Questionnaire and Visual Analogue Scale for Breathlessness) were
completed in March 2015. Institutional review board approval for the evidence based
practice change project as a Type 1 review was granted through Misericordia
University’s Institutional Review Board on May 11, 2015 (Appendix C).
Potential Risks and Benefits
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There is a low potential risk with participation in this project and any risks for
participation are the same as those for usual care. The project does not involve the
administration of any medications or other interventions that would expose the
participants to unnecessary risks. Benefits of this project may include symptom relief
and the improvement in the quality of care for patients with COPD. Participants will be
provided education on the proper use and frequency of incentive spirometry. The
Advanced Practice Nurse (APN) who practices in the location where the project was
conducted led the educational interventions. There are vulnerable populations that are
served by the clinical site, such as the underinsured and uninsured.
Project Design
The evidence based practice change project, The Effectiveness of Implementing
Standard of Care Best Practices Including Use of Daily Incentive Spirometry to Improve
Dyspnea and Quality of Life in Adults with Chronic Obstructive Pulmonary Disease
(COPD), was designed to be implemented at the time of visit to the urgent care setting
for COPD patients experiencing the sensation of dyspnea and reporting a decreased
quality of life. Educational sessions were designed to last for a period of 30 to 60
minutes, depending on patient participation and readiness to learn.
The Rosswurm and Larrabee (1999) Model for Change to Evidence-Based
Practice was chosen to serve as the conceptual framework for the design of this evidence
based practice change project. The primary aim of the model is guide healthcare
professionals through a systematic process for the change to evidence-based practice
(Rosswurm & Larrabee, 1999). The model guides practitioners through the entire
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process of change in evidence-based practice, beginning with the assessment of need for
the change and ending with the integration of an evidence-based protocol (Rosswurm &
Larrabee, 1999).
Planning of the practice change project focused on methods to improve quality of
life and dyspnea in patients with COPD. Goals and objectives of the project were
identified as the improved sensation of dyspnea, improved quality of life, and improved
outcomes achieved in the care of these individuals.
The project plan was to identify those individuals with COPD upon presentation
to the clinical site. Once identified, these individuals were to be instructed on the use of
incentive spirometry to improve inspiratory muscle strength and decrease dyspnea and
improve quality of life. The plan included patient instruction on the proper use and
frequency of incentive spirometry. Individuals were to be given the St. George’s
Respiratory Questionnaire and Visual Analogue Scale for breathlessness to complete
prior to their participation in the project and at the end of the project in order to assess the
effectiveness of the intervention. The plan included giving patients a daily symptom
diary to keep track of their symptoms and also to assess compliance with the intervention.
The plan included telephone calls to participants every two weeks for the duration of the
project to ensure compliance and provide encouragement. Prior to participation in the
project, participants were required to sign informed consent.
Data Collection Tools
The St. George’s Respiratory Questionnaire (SGRQ) (Appendix D) is a diseasespecific instrument that was designed to measure impact on overall health, daily life, and

39

perceived well-being in patients with obstructive airway disease (St. George’s University
of London, 2005). It was developed and validated in patients with COPD and asthma
(St. George’s University of London, 2005). Test-to-test reliability has been shown to be
0.795 to 0.900 and the questionnaire’s validity, reproducibility, and response to change
over time have been demonstrated (Basoglu, Atasever & Backagolu, 2005; St. George’s
University of London, 2005). The tool has three components: symptoms, activity, and
impact and the responses to these scores in these components can be aggregated into an
overall score, from 0 to 100, with higher scores indicating a poorer quality of life
(Basoglu, Atasever & Backagolu, 2005). The St. George’s University of London Medical
School grants permission for clinicians to use the SGRQ free of charge (St. George’s
University of London, 2005).
The Visual Analogue Scale (VAS) (Appendix E) is a tool to measure the intensity
or frequency of various symptoms, including breathlessness (Dauphin, Guillemin, Virion
& Briancon, 1999). The VAS has been used for its simplicity and adaptability to a broad
range of populations (Dauphin, Guillemin, Virion & Briancon, 1999). It is more
sensitive to small changes and is of most value when looking at changes within
individuals (Dauphin, Guillemin, Virion & Briancon, 1999). The VAS is available in
public domain at no cost and its test-retest reliability has been shown to be reliable (0.90;
95% CI; 0.88-0.92) (Badia, Monserrat, Rose & Herdman, 1999; Dauphin, Guillemin,
Virion & Briancon, 1999).
The daily symptom diary (Appendix F) was created by this author as a way for
participants to record their COPD symptoms on a daily basis and as a way for the patients
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to keep track of their IMT performance.
Resources Needed
Resources needed for the successful implementation of this evidence based
practice change project include copy paper, ink cartridges, a printer to print out the initial
SGRQ, VAS, and daily symptom diary, a copier to make copies for other participants in
the study, a telephone line and telephone available to call participants every two weeks
for compliance, an exam room in the clinical site to perform the education necessary for
participation in the proposed project, incentive spirometers, and a medical assistant to
obtain vital signs and place the participants in an exam room.
Budget Justification
A budget is the financial expression of a project and should accurately reflect the
costs of the proposed evidence based project and includes proposed direct costs, proposed
indirect costs, and estimated program income (USF Health, 2015). The proposed
evidence based practice change project will not be receiving funding from any local,
state, or federal governments or other outside sources. No participants of the project will
be provided with fringe benefits for their participation in the project. Salaries and wages
of the staff involved, which include the medical assistant and advanced practice nurse,
are paid for by the clinical site.
The direct costs of the proposed practice change project include one case of copy
paper at $27.29 per case, one set of printer cartridges in black ink at $35.99 per package,
incentive spirometers from Voldyne Medical Corporation at approximately $7.98 each.
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The total cost of incentive spirometers will vary depending on the amount of participants
in the project. If the project included twenty participants, the total estimated cost of the
incentive spirometers would be $159.60. Indirect costs include the time spent by the
project mentor in supervising the project and offering services for mentorship during the
project which are being provided by the project mentor as a voluntary effort.
Summary
Improving inspiratory muscle strength and endurance is a strategy that may help
to relieve the sensation of dyspnea, which leads to an increased level of activity and
improved quality of life in individuals with COPD (Geddes, Reid, Crowe, O’Brien &
Brooks, 2005). Improving the quality of life and decreasing dyspnea in these individuals
can lead to optimal outcomes in disease management. The use of incentive spirometry
and inspiratory muscle training has been shown to improve both muscle strength and
endurance and improve the sensation of dyspnea in patients with COPD (Heydari, Farzad
& Hosseini, 2013). This project serves to implement standard of care best practices in
the care of adults with COPD to improve outcomes in this population and to lead to
improved disease management.
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Chapter 5
Implementation Procedures and Processes
According to GOLD (2014), non-pharmacologic therapies are used as adjunctive
therapy in the treatment of individuals with COPD. One of these therapies is known as
pulmonary rehabilitation, which has a goal of reducing symptoms, improving quality of
life, and increasing physical participation in everyday activities (GOLD, 2014).
Inspiratory muscle training is a form of pulmonary rehabilitation. There are many
benefits to pulmonary rehabilitation such as reduction of dyspnea, improved health
related quality of life, reduced hospitalizations, and improved strength of respiratory
muscles when IMT is used (GOLD, 2014). This EBP change project attempted to
strengthen the respiratory muscles in these individuals, leading to decreased dyspnea,
improved quality of life, and improved outcomes in these patients.
Setting for Practice Change
The setting for the project was a small outpatient clinic located in the Pocono
Mountains of Pennsylvania. Clinical staffing included three nurse practitioners, a
collaborating physician, practice manager, office manager, and one medical assistant.
Teaching activities were conducted in patient exam rooms, which provided for comfort
and privacy during visits to the clinic. Permission was obtained from the Practice
Manager to conduct the project at the practice site (Appendix G). The clinic was easily
accessible to all participants and was handicapped accessible if needed, with ample
parking.
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Participants
Participants were adults, ages 45-70, with a diagnosis of COPD and who may be
currently taking medications for their symptoms. For inclusion in the project, patients
had to be English speaking and medically compliant with treatment. Participants would
be required to read and sign the consent form prior to participation in the project
(Appendix H).
Justification of the Practice Change
The current clinical site for the implementation of the practice change has
provided care to patients with COPD since its inception. Many of these patients are on
daily medications and treatment regimens for their disease yet continue to experience the
effects of dyspnea and decreased quality of life. The addition of inspiratory muscle
training to the treatment regimens of these patients may lead to a decrease in dyspnea and
improvement in their quality of life, leading to improved outcomes in the care of these
patients.
Implementation Procedures
The practice change project was implemented as described below.
Phase I: After the EBP project was approved by the Institutional Review Board at
Misericordia University, staff at the clinical site was educated on the purpose of the
project and which patients would benefit from participation. The training was conducted
at the clinical site of the proposed practice change. Only individuals with a diagnosis of
COPD, who were ages 45-70, English speaking, and were known to be compliant with
medical care were eligible for participation in the project.
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Phase II: When patients meeting the inclusion criteria presented to the clinic with
symptoms, the EBP project was explained to them in detail with the opportunity to ask
questions. Once they agreed to participate in the project, informed consent for a
retrospective chart review was obtained. Each participant completed a baseline SGRQ
and VAS and was educated in the use of the incentive spirometer. Participants were
enrolled in the project on a rolling basis and were given daily symptom diaries to keep
track of their symptoms and received follow up telephone calls every two weeks.
Phase III: When each participant reached a participation period of eight weeks in the
project, they were asked to complete a second VAS and SGRQ to gauge their symptoms
and a retrospective chart review was performed to extract data for analysis. Once all
participants completed the study and data was extracted, an analysis of the data was
performed.
Task List with Timeline
A timeline for the project was developed to ensure that goals and objectives were
successfully completed (Appendix I). The timeline allowed for advanced preparation of
project activities and to make adjustments to the project as needed. A summarization of
the timeline for the evidence based practice change project can be found in Appendix A.
Summary
Implementation of this project targeted dyspnea and decreased quality of life,
which are the most common symptoms that patients with COPD experience. Improving
these symptoms in these individuals allows them to live a more productive and
meaningful life without the stressful burden that these symptoms create. Incorporating
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standard of care best practices in the routine care of individuals with COPD can lead to
improved outcomes in this population.
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Chapter 6
Evaluation and Outcomes of Practice Change Project
Clinical outcomes are used to measure the success of interventions and treatments
in research and clinical trials. Measurement of outcomes is important to determine and
document the impact of the evidence-based practice change on patient outcomes (Melnyk
& Fineout-Overholt, 2011). Evaluation is an important component of the evidence based
practice project because it determines the effectiveness of the intervention. The purpose
of this evidence-based practice project was to implement an evidence-based intervention
from the literature to decrease dyspnea and improve quality of life in individuals with
COPD. This chapter describes the outcomes, statistical analysis of the data, comparison
of the results to project objectives, and the evaluation of the evidence-based practice
project.
Expected Outcomes
GOLD (2014) guidelines have established the primary goal for patients diagnosed
with COPD is to reduce symptoms, reduce the frequency of exacerbations, improve
health status, and restore effective daily functioning. The expected outcomes of the
evidence-based practice change project were based upon the premise of these guidelines.
Expected outcomes were to improve the symptom of dyspnea and improve quality of life
in individuals with COPD through the use of daily incentive spirometry.
The Visual Analogue Scale (VAS) and St. George’s Respiratory Questionnaire
(SGRQ) were tools used to measure the outcomes of dyspnea and quality of life for the
evidence-based practice project. The instruments, as described in Chapter Four, are a
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self-reported scale and questionnaire that are condition specific to COPD. The VAS
addresses perceived level of breathlessness on a scale of one to ten. The SGRQ is a 14
item questionnaire that addresses the symptoms of the disease, the impact of the disease
on the patient, and how the disease affects the patient’s activity level.
Outcomes were evaluated based on the numerical scores from the VAS and the
total scores from the SGRQ. The evidence-based practice project was designed for
participants, ages 45-70, with a diagnosis of COPD. Ten individuals were approached
regarding participation in the project, one refused. The project was implemented with
nine participants.
The participants were examined and evaluated in the outpatient setting by this
investigator. The initial visit consisted of agreement to participate, instruction on the use
and frequency of incentive spirometry, and completion of the VAS and SGRQ for
baseline scores pre-intervention. Telephone calls were placed to participants every two
weeks to assess compliance. At the end of the eight week intervention period,
participants completed a post-intervention VAS and SGRQ. At the end of the
intervention period a retrospective chart review was also performed to determine if there
was a decrease noted in the participant’s symptoms.
Data Analysis and Results
In accordance with published scoring instructions for the SGRQ, each positive
answer was given a predetermined weighted score and a total score was determined by
the addition of each positive score and dividing that number by the total possible score
for the entire test, then multiplying the answer by one-hundred. The VAS scores were
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subjective numerical scores based on the sensation of symptoms pre- and postintervention.
A significance level was established at 0.05 prior to implementation of the project
to be considered effective and to weigh the strength of the evidence. Data was entered
into Excel when questionnaires were completed for pre- and post-intervention VAS and
SGRQ scores. Once all data were obtained, a two-tailed, paired t-test was performed
through Excel to determine the effectiveness of the intervention.
Improvement was noted in VAS scores of most participants, with a reduction of
one to two points in eight participants noted after the intervention period (Appendix J).
One participant did not note a change in the sensation of dyspnea during the protocol.
The two-tailed p-value was less than the significance level of 0.05 and the t-value was
2.306, which indicates statistical significance of the results and effectiveness of the
intervention in decreasing dyspnea in patients with COPD (Table 1). There was a 23%
decrease noted in scores on the VAS after the use of IMT.
Mean 1

SD 1

Mean 2

SD 2

p-value

5.22

1.30

4

0.87

0.0006

Percent
Change
23%
decrease in
scores

Table 1. Mean 1: The mean of pre-intervention scores; SD1: The standard deviation of pre-intervention
scores; Mean 2: The mean of post-intervention scores; SD 2: The standard deviation of post-intervention
scores.

Improvement was noted in SGRQ scores of all participants at the end of the
intervention period (Appendix J). The two-tailed p-value was less than the significance
level of 0.05 and the t-value was 2.31, which indicates statistical significance of the
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results and effectiveness of the intervention in improving quality of life in patients with
COPD (Table 2). There was a 21% decrease in scores of the SGRQ after the use of IMT.
Mean 1

SD 1

Mean 2

SD 2

p-value

51.9

17.8

40.9

16.1

0.00002

Percent
Change
21%
decrease in
scores

Table 2. Mean 1: The mean of pre-intervention scores; SD1: The standard deviation of pre-intervention
scores; Mean 2: The mean of post-intervention scores; SD 2: The standard deviation of post-intervention
scores.

Relationship of Results to Framework/Objectives
An evidence-based practice project was implemented over an eight week period
with COPD patients in the outpatient care setting. The objective of the project was to
implement an evidence-based practice protocol using incentive spirometry as a form of
inspiratory muscle training when treating patients with COPD who present with dyspnea
and impaired quality of life. Measurement outcomes were identified and measurement
tools were chosen. Benchmarks for the measurement of outcomes were determined
through literature review.
The first defined outcome was a decrease in dyspnea in patients with COPD
through the daily use of incentive spirometry. Having achieved a reduction in VAS
scores that was statistically significant is an encouraging finding that enables the practice
change to be introduced into practice and expanded upon to optimize outcomes.
The second defined outcome was improvement in quality of life in patients with
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COPD through the daily use of incentive spirometry. Having achieved a reduction in
SGRQ scores that was statistically significant is encouraging, and enables the change to
be introduced into practice to improve outcomes in this population.
The findings of a positive correlation between a reduction in dyspnea and the use
of daily incentive spirometry is not unexpected. The implications of the need to add IMT
to the plan of care for COPD patients became apparent as a result of this evidence-based
practice project. There are direct project implications that will make an impact locally
with the COPD population.
The Model for Evidence Based Practice Change by Rosswurm and Larrabee
(1999) was the conceptual model used in this evidence-based practice change project.
The model integrates the principles of quality improvement, use of teamwork tools, and
evidence-based translation strategies to promote the adoption of a new practice (Melnyk
& Fineout-Overholt, 2011). It was determined that impaired respiratory muscle strength
was a problem in patients with COPD and that improvement of this would be of great
benefit to those with the disease. Multiple interventions were explored through a review
of the literature to determine which would be the most beneficial in this population and
the use of incentive spirometry as a form of IMT was determined to provide significant
improvement for both outcomes and the change was implemented in the practice setting.
Once data is obtained from the protocol, it can be used as feedback to decide if the
practice change should be adapted, adopted, or rejected based on the feasibility, risks, and
benefits (Melnyk & Fineout-Overholt, 2011), which was done in this practice project.
When analyzing the data, it was found that daily incentive spirometry did improve the
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symptoms of dyspnea and quality of life in patients with COPD. The improvement in
dyspnea was found to be statistically significant for this population, however, the
improvement in quality of life was found to not be statistically significant for this project
population. These results lead this investigator to question how the new practice should
be adapted or revised in order to provide more significant results and implemented into
everyday practice. A potential revision for the project would be to implement the change
in a larger population in order to get a sample size that is may show more of an effect
from the intervention. Another revision for the project would be to implement the change
for a longer period of time such as twelve weeks or sixteen weeks, which would provide
information regarding the long term effects of the intervention in this population.
Today’s healthcare environment is supportive of evidence-based practice that will
improve the quality of patient care and enhance clinical judgement and this practice
change project has the potential to do just that. With some minor revisions, this
evidence-based practice change project has the potential to improve the quality of care in
patients with COPD and lead to improved outcomes and standards of care.
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Chapter 7
The profession of nursing involves the protection, promotion, and optimization of
health, prevention of illness and injury, alleviation of suffering through the diagnosis and
treatment of human response, and advocacy in the care of individuals, families,
communities, and populations (American Nurses Association (ANA), 2015). Advanced
practice nursing is defined as:
Any form of nursing intervention that influences health care outcomes for
individuals or populations, including the direct care of individual patients, management of
care for individuals and populations, administration of nursing and health care
organizations, and the development and implementation of health care policy (AACN,
2006, p. 4).
The Doctor of Nursing Practice (DNP) graduate is prepared to investigate and
solve problems facing our healthcare system and to deliver the highest level of nursing
practice in order to achieve optimal outcomes (Zaccagnini & White, 2014). The DNP
must be constantly aware of and knowledgeable about changes in practice to ensure that
current best practice is maintained (Zaccagnini & White, 2014).
This chapter will discuss the strengths and limitations of the evidence-based
practice project, the implications for nursing practice, and the linkage of the project to the
eight Essentials of Doctoral Education for Advanced Nursing Practice introduced by the
AACN (2006).
Limitations of the Project
It should be noted that there was a significant decrease in the number of patients
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seen within the population of interest once implementation of the project began in late
May. A larger sample size may have yielded more positive results and may have been
more representative of the population of interest. The project proceeded despite the
limited number of patients presenting with symptoms of COPD. Another limitation of
the project was the limited time period of 12 weeks within which to complete the project.
If individuals presented with symptoms of COPD after the enrollment period, they were
excluded due to the inability to perform the intervention for a period of eight weeks.
Replication of the project for an extended period of time such as four to six months may
strengthen the evidence based practice project and provide information regarding the long
term effects of the intervention. Extension of the end age range of participants from 70 to
80 may provide for more participants in future projects, lending strength to the practice
change project.
Implications for Nursing Practice
DNP prepared nurses have the ability to integrate nursing science with knowledge
from other areas such as ethics, the biophysical, psychosocial, analytical, and
organizational sciences and use it as the basis to provide the highest level of nursing
practice (AACN, 2006). Strategies are needed to improve care delivery in individuals
with COPD. The DNP possesses a wide array of knowledge from the sciences and has
the ability to translate that knowledge to effectively benefit patients in the daily demands
of the practice environment (AACN, 2006).
All of the participants of this evidence based practice project were on daily
medications for their COPD and still experiencing symptoms daily, yet not one has ever
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participated in a pulmonary rehabilitation program or performed inspiratory muscle
training at an attempt to improve their symptoms. The current state of management of
COPD consists of a multidisciplinary approach to patient care and pulmonary
rehabilitation is now being recognized as an important part of the management of patients
with COPD (Shinde, Kiran, Khatari & Hande, 2012). The APN plays a key role in the
identification of potential candidates for pulmonary rehabilitation and in facilitating and
reinforcing the material learned in order to ensure optimal outcomes in this population
(Heydari, Farzad & Hosseini, 2013). Patients with COPD experience respiratory muscle
weakness which may contribute to dyspnea being considered the most debilitating
symptom in these patients (Heydari, Farzad & Hosseini, 2013). Using incentive
spirometry for inspiratory muscle training is an important component of the routine
rehabilitation protocol for patients with COPD and can greatly enhance the APN’s ability
to provide COPD patients with quality, accessible care and improve outcomes in this
population (Heydari, Farzad & Hosseini, 2013).
Linkage to DNP Essentials
Essential I: Scientific Underpinnings for Practice. The DNP possesses a wide array of
knowledge gained from the sciences and has the ability to quickly and effectively benefit
patients in the daily demands of today’s practice environments (AACN, 2006). The DNP
is able to use science-based theories and concepts in order to determine the nature and
significance of health and healthcare delivery phenomena, describe actions and advanced
strategies to enhance, alleviate, and improve health and healthcare delivery in
populations, and evaluate outcomes (AACN, 2006). This evidence based practice project
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used scientific evidence combined with concepts and theories to enhance and improve
care delivery in individuals with COPD. The Model for Change to Evidence-Based
Practice by Rosswurm & Larrabee (1999) was used to guide the APN through a
systematic process for change to the standard of care that was provided to individuals in
this population. Evidence was obtained from various sources in support of the use of
IMT to decrease dyspnea and improve quality of life in individuals with COPD and was
used to plan and implement the evidence based practice project.
Essential II: Organizational and Systems Leadership for Quality Improvement and
Systems Thinking. Using organizational and systems leadership is important to improve
patient and healthcare outcomes (AACN, 2006). Using the knowledge and skills of the
DNP in these areas is consistent with nursing goals to eliminate health disparities and to
promote excellence in practice (AACN, 2006). In order to improve outcomes in
populations, the DNP must be proficient in quality improvement strategies and have the
ability to evaluate the cost-effectiveness of care in order to ensure effective care delivery
strategies (AACN, 2006). COPD is a disease that affects individuals of all
socioeconomic classes but poverty has been shown to be a risk factor for development of
the disease (GOLD, 2014). The disease can occur as a result of the individual’s
environment and may be prevalent where health disparities occur. The incentive
spirometer is an inexpensive, simple device that can be used to perform IMT and can be
used to improve outcomes in this population and enhance access to care.
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice.
The DNP prepared nurse is able to translate research into practice and use analytical
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methods to critically appraise existing literature to determine and implement the best
evidence for practice (AACN, 2006). A methodical search of healthcare databases
resulted in evidence that supported the use of IMT in patients with COPD in order to
improve dyspnea and improve quality of life. Through critical analysis, only the
strongest and most reliable evidence was chosen to support this practice change project.
The evidence obtained was then used to design, direct, and evaluate quality improvement
methodologies to promote safe, timely, effective, and quality patient-centered care.
Essential IV: Information Systems/Technology and Patient Care Technology for the
Improvement and Transformation of Healthcare. The knowledge of information systems
and technology allows the DNP to apply new knowledge, manage individual and
aggregate level information, and assess the efficacy of patient care technology (AACN,
2006). The ability to design and use information systems and technology to evaluate
programs of care and outcomes of care is an essential skill of the doctorally prepared
nurse (AACN, 2006). Information systems and technology were used in this practice
change project in order to determine the impact that COPD has within populations,
design an evidence-based intervention, predict and analyze outcomes, and identify gaps
in evidence for practice. Data analysis was performed using information technology in
order to evaluate the outcomes of this project. It was predicted that daily use of IMT in
individuals with COPD would result in decreased dyspnea and improved quality of life in
this population and through analysis of the data, it was determined that there was an
improvement in symptoms in patients who participated in the evidence-based practice
project.
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Essential V: Health Care Policy for Advocacy in Health Care. Health care policy can
facilitate or impede the delivery of healthcare services or the ability of the provider to
engage in practice to improve health care needs (AACN, 2006). It is important that the
DNP is able to design, implement, and advocate for healthcare policy that addresses
issues of social injustice and equity in healthcare (AACN, 2006). This evidence based
practice change project applied a cost-effective intervention that can be used in areas of
health disparities in order to improve healthcare outcomes within the population, thereby
eliminating social injustice in the delivery of healthcare. The results from this practice
change project can be used to educate others regarding improving outcomes in patients
with COPD.
Essential VI: Interprofessional Collaboration for Improving Patient and Population
Health Outcomes. Today’s healthcare environment depends on contributions from highly
skilled and knowledgeable individuals from multiple professions in order to accomplish
the Institute of Medicine’s (IOM) mandate for safe, timely, effective, efficient, equitable,
and patient-centered care (AACN, 2006). This evidence-based practice change project
occurred as part of a collaborative effort involving various staff members in the clinical
setting in order to improve the standard of care provided to patients with COPD.
Effective communication and leadership skills were employed to lead the
interprofessional team in implementation of the EB project and improving population
health outcomes.
Essential VII: Clinical Prevention and Population Health for Improving the Nation’s
Health. The implementation of clinical prevention and population health activities is
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central to achieving the national goal of improving the health status of the population of
the United States (AACN, 2006). The DNP can engage in leadership to integrate
evidence-based clinical prevention and population health services for individuals and
populations (AACN, 2006). Data were evaluated that show the incidence and prevalence
of COPD is higher in populations with lower socioeconomic status and that regardless of
socioeconomic status, COPD is becoming an ever increasing social and financial burden
in the United States. When evaluating patient records, it was determined that many of the
patients with COPD have never been involved in any form of pulmonary rehabilitation
and continue to present with symptoms of the disease. This information was used to
develop an evidence-based practice change project focusing on a cost-effective form of
IMT that can be used by anyone diagnosed with COPD in order to improve healthcare
outcomes in populations and address gaps in care.
Essential VIII: Advanced Nursing Practice. The DNP is able to design, implement, and
evaluate therapeutic interventions based on nursing science as well as develop and sustain
therapeutic relationships and partnerships with patients and other professionals to
facilitate optimal care and patient outcomes (AACN, 2006). A therapeutic relationship
was developed with each participant in order to ensure their trust in the information and
care provided to them. The evidence-based practice project was designed to be simple
and easy to apply in any type of practice setting. Once a patient met inclusion criteria,
the project was explained to them in detail with the opportunity to ask questions. They
were then instructed on the protocol and evaluated at the beginning and end of a period of
eight weeks. A retrospective chart review was then performed to determine if an
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improvement in daily symptoms was seen. Through participation of the participants in
the protocol, improvement was shown in the standard of care for patients with COPD.
Summary
COPD is a leading cause of morbidity and mortality worldwide and results in an
economic and social burden that is substantial and increasing, which makes control of
symptoms and improvement of outcomes important (GOLD, 2014). There are various
therapeutic treatment options for COPD encompassing pharmacologic and nonpharmacologic therapies, and IMT has been found to be beneficial to patients with COPD
when used as part of a pulmonary rehabilitation program (GOLD, 2014). The principal
goals of a pulmonary rehabilitation program are to reduce symptoms, improve quality of
life, and increase physical and emotional participation in everyday activities (GOLD,
2014). The DNP has the ability to investigate and solve the problems facing our
healthcare system today and deliver the highest level of nursing practice in order to
achieve optimal outcomes (Zaccagnini & White, 2014), which would be essential in the
care of individuals with COPD. Findings from this project determined a need to include
the use of IMT in the care plan of individuals with COPD, along with pharmacologic
therapies, in order to improve outcomes and the standard of care in this population. The
results of the project also confirmed evidence from existing literature that using IMT can
improve dyspnea and improve quality of life in these patients. The DNP can design,
direct, and implement quality improvement activities to promote safe, timely, effective,
and patient-centered care and must be constantly aware of and knowledgeable about
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changes in practice to ensure that current best practice is maintained (AACN, 2006;
Zaccagnini & White, 2014).
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Chapter 8
Summary and Conclusions
The symptoms of dyspnea and decreased quality of life can be frustrating
to individuals with COPD. The desired outcome of this evidence-based practice project
was to improve these symptoms in COPD patients with evidence supported IMT and
improve outcomes in this population.
The implementation of this project involved a change in practice based upon the
best evidence available. A review and analysis of the literature indicated that individuals
with COPD can strengthen their respiratory muscles through IMT. Evidence from major
studies supports the use of IMT in patients with COPD to improve quality of life and
decrease dyspnea. COPD may be treated with systemic corticosteroids, inhaler
corticosteroids, and long and short acting beta-agonists, however, many individuals
continue to experience daily symptoms of the disease. GOLD (2014) guidelines
recommend pulmonary rehabilitation as a form of adjunct therapy in these patients and
IMT is an aspect of this.
This practice change project arose out of a need to improve standard of care best
practices for COPD patients. Many patients were presenting to the outpatient setting with
complaints of symptoms and frequent exacerbations, leading to increased healthcare costs
and patient dissatisfaction with care. Planning of the project with preceptor and clinician
involvement began seven months prior to implementation of the project.
Development of the protocol provided guidance for the implementation of the
intervention and required the clinician and staff to explain the use and frequency of
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incentive spirometry and request that participants complete an SGRQ and VAS for a preintervention baseline.
Based on project evaluation data, this project accomplished the intended
outcomes as evidenced by the improved VAS and SGRQ scores. There was at least a one
point improvement in every participant’s VAS scores, and activity scores improved in
patients that were involved in the protocol.
The successful implementation of this project indicates that evidence-based
practice projects can be used to improve the standard of care provided to COPD patients.
The strategic planning of the project with all staff involved alleviated barriers to
implementation. Using the Model for Change to Evidence Based Practice by Rosswurm
& Larrabee (1999) enabled the change to be implemented smoothly.
There is an abundance of research available on the care of COPD patients but
there is limited research on the use of IMT and incentive spirometry to improve
symptoms in COPD patients. The limited research conducted on the use of IMT for
symptom improvement in COPD patients indicates an opportunity for future research in
this area. The treatment protocol developed for this project is based on the best available
scientific evidence and may be replicated in other practice settings and by disciplines
other than nursing.
By developing a treatment protocol for adult patients with COPD, treatment
recommendations were appropriate for all ages of individuals with this disease. This
project resulted in a reduction of symptoms and improved quality of life, leading to
improved outcomes and the provision of optimal care to patients with COPD.
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Dissemination Plans
Dissemination of nursing knowledge is essential for APN’s (Hanrahan, Marlow,
Aldrich & Hiatt (2010). In order to maintain the highest standards of care, nurses need to
be aware of the most recent and relevant research and use this knowledge to inform their
practice (Cheek, Gillham & Ballantyne, 2005). Being able to contribute, effectively use,
and communicate knowledge to nurses, colleagues, policy makers, and the public via
publications, posters, and presentations is crucial for the profession of nursing (Hanrahan,
Marlow, Aldrich & Hiatt (2010).
Dissemination plans for this evidence-based practice project include a discussion
of the results with other colleagues involved in the care of individuals with COPD, the
implementation of IMT in current practices for COPD, submission of a manuscript of the
project for publication in nursing journals, the implementation of a journal club in the
practice site once per month after the staff meeting, and a discussion of the project results
with local COPD patients through seminars and workshops. The dissemination of results
from this evidence-based practice project can improve the standard of care for individuals
with COPD as well as lead to improved outcomes in this population.
Future Ideas/Next Steps Related to Project
Future ideas for this evidence-based practice project include the implementation
of IMT in practice with all patients with a diagnosis of COPD. Patients outside of the
project age range of 45-70 may also benefit from use of IMT. Even the slightest
improvement in symptoms may be meaningful to these individuals. Another thought is to
vary the length of the project, with a potentially shorter intervention period of four weeks
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to determine if participants would see improvement in their symptoms in a shorter period
of time. Consideration should also be given to extending the length of the intervention
period to twelve weeks to determine if there is a greater benefit to patients when using
IMT for a longer period of time. Various studies (Heydari, Farzad & Hosseini, 2013;
Satani, Khuman, Devi & Nambi, 2013) have suggested lengthening the intervention
period to determine the long term effects of IMT in this population, to determine if IMT
with incentive spirometry has a more permanent effect on pulmonary functions, reduced
exacerbations, and the reduced frequency of use of bronchodilators. The short period of
eight weeks only shows the short term, immediate effects of the intervention.
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Appendix A

The Rosswurm and Larrabee Model for EBP Change
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Appendix D
ST. GEORGE’S RESPIRATORY QUESTIONNAIRE for COPD patients
(SGRQ-C)
This questionnaire is designed to help us learn much more about how your breathing is
troubling you and how it affects your life. We are using it to find out which aspects of
your illness cause you most problems, rather than what the doctors and nurses think your
problems are.
Please read the instructions carefully and ask if you do not understand anything. Do not
spend too long deciding about your answers.
ID: __________________________
Date: ______/________/________ (dd/mm/yy)
Before completing the rest of the questionnaire:
Please select one box to show how you describe your current health:


Very good


Good
Fair



Poor



Very poor



Version: 1st Sept 2005
Copyright reserved P.W. Jones, PhD FRCP Professor of Respiratory Medicine, St.
George’s University of London, Cranmer Terrace London SW17 ORE, UK.
Tel. +44 (0) 20 8725 5371 Fax +44 (0) 20 8725 5955
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UK/ English version COPD
SGRQ-C - United Kingdom/English SGRQ-C_AU1.0_eng-GBori.doc
St. George’s Respiratory Questionnaire PART 1
Questions about how much chest trouble you have.
Please select ONE box for each question:
Question 1.
I cough:
most days a week........................

a

several days a week....................

b

only with chest infections...........

c

not at all......................................

d

Question 2. I bring up phlegm (sputum):
most days a week........................

a

several days a week....................

b

only with chest infections...........

c

not at all......................................

d

Question 3. I have shortness of breath:
most days a week........................

a

several days a week....................

b

not at all......................................

c

Question 4. I have attacks of wheezing:
most days a week........................

a
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several days a week....................

b

a few days a month.....................

c

only with chest infections...........

d

not at all......................................

e

Question 5. How many attacks of chest trouble did you have during the last year?
3 or more attacks ........................

a

1 or 2 attacks...............................

b

none............................................

c

Question 6. How often do you have good days (with little chest trouble)?
no good days...............................

a

a few good days..........................

b

most days are good.....................

c

every day is good........................

d

Question 7. If you have a wheeze, is it worse in the morning?
no................................................



yes............................................... 
St. George’s Respiratory Questionnaire PART 2
8. How would you describe your chest condition?
Please select ONE:
Causes me a lot of problems or is the most important problem I have .........

a

Causes me a few problems ...........................................................................

b

Causes no problem........................................................................................

c
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9. Questions about what activities usually make you feel breathless.
For each statement please select the box that applies to you these days:
True False
Getting washed or dressed......................................................................

 a

Walking around the home........................................................................

 b

Walking outside on the level....................................................................

 c

Walking up a flight of stairs......................................................................

 d

Walking up hills........................................................................................

 e

10. Some more questions about your cough and breathlessness.
For each statement please select the box that applies to you these days:
True False
My cough hurts.....................................................................................
My cough makes me tired ....................................................................
I am breathless when I talk...................................................................
I am breathless when I bend over ........................................................

 a
 b
 c
 d

My cough or breathing disturbs my sleep.............................................

 e

I get exhausted easily...........................................................................

 f

11. Questions about other effects that your chest trouble may have on you.
For each statement please select the box that applies to you these days:
True False
My cough or breathing is embarrassing in public.................................

 a

My chest trouble is a nuisance to my family, friends or neighbours.....

 b
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I get afraid or panic when I cannot get my breath................................

 c

I feel that I am not in control of my chest problem................................

 d

I have become frail or an invalid because of my chest.........................

 e

Exercise is not safe for me...................................................................

 f

Everything seems too much of an effort...............................................

 g

12. These are questions about how your activities might be affected by your breathing.
For each statement please select the box that applies to you because of your
breathing:

True False

I take a long time to get washed or dressed...........................................

 a

I cannot take a bath or shower, or I take a long time.............................

 b
 c

I walk slower than other people, or I stop for rests.................................
Jobs such as housework take a long time, or I have to stop for rests....  d
If I walk up one flight of stairs, I have to go slowly or stop.....................

 e

If I hurry or walk fast, I have to stop or slow down .................................

 f

My breathing makes it difficult to do things such as walk up hills, carrying things up
stairs, light gardening such as weeding, dance, play bowls or play golf ....   g
My breathing makes it difficult to do things such as carry heavy loads, dig the garden or
shovel snow, jog or walk at 5 miles per hour, play tennis or swim...............  h
13. We would like to know how your chest trouble usually affects your daily life.
For each statement please select the box that applies to you because of your breathing:
True False
I cannot play sports or games ................................................................

 a
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I cannot go out for entertainment or recreation......................................

 b

I cannot go out of the house to do the shopping....................................

 c

I cannot do housework ...........................................................................

 d

I cannot move far from my bed or chair..................................................

 e

14. How does your chest trouble affect you?
Please select ONE:
It does not stop me doing anything I would like to do .................

a

It stops me doing one or two things I would like to do.................

b

It stops me doing most of the things I would like to do................

c

It stops me doing everything I would like to do............................

d

Thank you for filling in this questionnaire.
Before you finish, would you please check to see that you have answered all the
questions.
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Appendix E
VISUAL ANALOGUE SCALE FOR BREATHLESSNESS

Please rate the severity of your daily sensation of shortness of breath on this scale from
1-10, with 1 meaning having no shortness of breath at all, 5 meaning moderate shortness
of breath, and 10 being short of breath as bad as can be.

_________________________________________________________
1
No
Shortness
of breath

2

3

4

5

6

7

8

9

10

Moderate

Severe

shortness

shortness

of breath

of
breath
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Appendix F
Daily Symptom Diary
Week 1
Day 1
________________________________________________________________________
Day 2
________________________________________________________________________
Day 3
________________________________________________________________________
Day 4
________________________________________________________________________
Day 5
________________________________________________________________________
Day 6
________________________________________________________________________
Day 7
________________________________________________________________________
Week 2
Day 1
________________________________________________________________________
Day 2
________________________________________________________________________
Day 3
________________________________________________________________________
Day 4
________________________________________________________________________
Day 5
________________________________________________________________________
Day 6
________________________________________________________________________
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Day 7
________________________________________________________________________
Week 3
Day 1
________________________________________________________________________
Day 2
________________________________________________________________________
Day 3
________________________________________________________________________
Day 4
________________________________________________________________________
Day 5
________________________________________________________________________
Day 6
________________________________________________________________________
Day 7
________________________________________________________________________
Week 4
Day 1
________________________________________________________________________
Day 2
________________________________________________________________________
Day 3
________________________________________________________________________
Day 4
________________________________________________________________________
Day 5
________________________________________________________________________
Day 6
________________________________________________________________________
Day 7
________________________________________________________________________
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Week 5
Day 1
________________________________________________________________________
Day 2
________________________________________________________________________
Day 3
________________________________________________________________________
Day 4
________________________________________________________________________
Day 5
________________________________________________________________________
Day 6
________________________________________________________________________
Day 7
________________________________________________________________________
Week 6
Day 1
________________________________________________________________________
Day 2
________________________________________________________________________
Day 3
________________________________________________________________________
Day 4
________________________________________________________________________
Day 5
________________________________________________________________________
Day 6
________________________________________________________________________
Day 7
________________________________________________________________________
Week 7
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Day 1
________________________________________________________________________
Day 2
________________________________________________________________________
Day 3
________________________________________________________________________
Day 4
________________________________________________________________________
Day 5
________________________________________________________________________
Day 6
________________________________________________________________________
Day 7
________________________________________________________________________
Week 8
Day 1
________________________________________________________________________
Day 2
________________________________________________________________________
Day 3
________________________________________________________________________
Day 4
________________________________________________________________________
Day 5
________________________________________________________________________
Day 6
________________________________________________________________________
Day 7
________________________________________________________________________
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Appendix G
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Appendix H
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Appendix H (con’t.)
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Appendix I
Timeline for Evidence Based Practice Change Project
Oct
2014
Project Stage
Practice Change
Identified
Review of
Literature
Organizational
Framework
Planning
Project Design
Project
Development
IRB approval
Implementation
Project
Implementation
Data
Compilation
Evaluation
Data Analysis
Interpretation of
Results
Dissemination
Presentation of
Results

Nov
2014

Dec
2014

Jan
2015

Feb
2014

March
2015

April
2015

May
2015

June
2015

July
2015

August
2015
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Appendix J

VAS Scores
8
7
6
5
4
3
2
1
0
1

2

3

4

5

Pre-intervention

6

7

8

9

Post-intervention

Figure 1. Visual Analogue Scale Scores Pre- and Post-Intervention
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Figure 2. St. George’s Respiratory Questionnaire Results Pre- and Post-Intervention
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